TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

Stock Information for Anika Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Anika Therapeutics Inc.

Anika Reports First Quarter 2026 Financial Results
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026
Telix Strengthens Board with Additional Director Appointments
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Anika Reports Fourth Quarter and Full Year 2025 Financial Results
Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference
Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.